Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics
Despite what managed care is doing to clinical laboratories, money abounds to sell more goods. In this issue, you will read about how AmeriPath, Inc. is about to raise $71.7 million while Cytyc Corp. intends to generate $48.2 million in its second public offering in 12 months. The list of laboratory-related companies which raised money …
Plenty Of Money To Go Around Read More »
CEO SUMMARY: AmeriPath’s Initial Public Offering will make it the first publicly traded physician practice management company specializing in pathology. It represents a unique attempt to restructure traditional pathology practices to meet the needs of managed healthcare organizations. PATHOLOGY ENTERS A NEW ERA when AmeriPath, Inc. completes its proposed Initial Public Offering (IPO) during the …
AmeriPath To Go Public, Files SEC Registration Read More »
CEO SUMMARY: Two fascinating aspects about the AmeriPath story are: 1) the strategy to boost share values; and 2) the strategy to develop profitable pathology revenues. With managed healthcare transforming pathology at an astounding rate, will AmeriPath succeed in both strategies? DURING THE LAST YEAR, intense curiosity swirled about AmeriPath, Inc. Pathologists heard plenty of …
AmeriPath’s Strategies For Business Success Read More »
CEO SUMMARY: Three public laboratories experiencing serious financial pressure enter the new year with a change in presidents. It is a sign that stockholders and creditors are growing increasingly restless with these organizations’ inability to earn satisfactory profits. Turnover among chief executive officers is usually not a good sign. During the last 45 days, three …
Three Public Laboratories Choose New Presidents Read More »
CEO SUMMARY: Long overlooked by most of the laboratory industry, ACLA may be in the process of revolutionary change. Since David Sundwall, M.D., became President, ACLA has taken a more assertive stance on a wide variety of issues which affect all laboratories, not just ACLA members. LONG CONSIDERED by most laboratory executives as a tight …
Laboratory Trade Group Launches New Activities Read More »
CEO SUMMARY: Armed with FDA premarket approval, Cytyc must now overcome significant obstacles to introduce its ThinPrep Pap smear system into widespread clinical usage. ANOTHER WELL-FINANCED competitor will soon enter the Pap smear marketplace. Cytyc Corporation is offering 3,000,000 shares to the public with the goal of raising $48.2 million. Cytyc will use $25 million …
Cytyc Corp. Raising $48 Million To Fund ThinPrep Sales Effort Read More »
Persistence can pay off. After years of struggle, Epitope, Inc. of Beaverton, Oregon received a big “shot inthe arm” when the Journal of the American Medical Association (JAMA) reported this month on a clinical study involving Epitope’s OraSure HIV test. The study involved 3,570 patients. It matched results of an HIV blood test against the …
“January 27, 1997 Intelligence: Late Breaking Lab News” Read More »
The Dark Report • 21806 Briarcliff Dr • Spicewood, TX 78669
Phone: 512-264-7103 • Toll Free Number: 800-560-6363
Email: info@darkreport.com
© 2024 The Dark Report. All rights reserved.